Rearrangement of the anaplastic lymphoma kinase (ALK) gene is observed in 2%–7% of NSCLC patients, and is particularly frequent in younger individuals, non-smokers, and those with adenocarcinoma (Kwak et al., 2010). Here, ALK is linked to adenocarcinoma.